Application Lodged to Conduct an HIV Clinical Trial in South Africa - 4 September 2006
Monday 4 September 2006
Virax has loged a Clinical Trial Applicaion (CTA) with the suth African Medicines Control Council (MCC) for approval to conduct a PhaseI/IIa trial of the VIR201 HIV vaccine.
231 - Application Lodged to Conduct an HIV Clinical Trial in South Africa - 4 September 2006
22 file